Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History $1.18 0.00 (0.00%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$1.18 0.00 (0.00%) As of 07/3/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Telomir Pharmaceuticals Stock Price Performance The Telomir Pharmaceuticals (TELO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 68.53%, with a year-to-date return of -71.36%. In the past month, the stock has decreased 44.08%, reflecting recent market activity. As of the latest close, Telomir Pharmaceuticals traded at $1.18 with a market cap of $35.12 million and volume of 235,925 shares. Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-22.88%1 Month Performance-44.08%3 Month Performance-59.73%Year-To-Date Performance-71.36%1 Year Performance-68.53% TELO Stock Chart for Friday, July, 4, 2025 TELO Chart by TradingView Telomir Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$1.18$1.18$1.20$1.15235,925 shs$35.12 million07/02/2025$1.27$1.18-7.09%$1.29$1.18267,671 shs$35.12 million07/01/2025$1.25$1.27+1.60%$1.37$1.19868,378 shs$37.80 million06/30/2025$1.53$1.25-18.30%$1.58$1.25378,553 shs$37.20 million06/27/2025$1.70$1.53-10.00%$1.68$1.522.25 million shs$45.53 million06/26/2025$1.78$1.70-4.49%$1.79$1.61392,329 shs$50.59 million06/25/2025$1.76$1.78+1.14%$1.81$1.68311,626 shs$52.97 million06/24/2025$1.69$1.76+4.14%$1.76$1.65356,012 shs$52.38 million06/23/2025$1.76$1.69-3.98%$1.79$1.66297,807 shs$50.29 million06/20/2025$1.76$1.76$1.85$1.76486,066 shs$52.38 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$1.76$1.76$1.97$1.71187,458 shs$52.38 million06/18/2025$1.86$1.76-5.38%$1.97$1.71187,458 shs$52.38 million06/17/2025$2.00$1.86-7.00%$1.96$1.85148,490 shs$55.36 million06/16/2025$1.96$2.00+2.04%$2.00$1.92117,149 shs$59.53 million06/13/2025$2.00$1.96-2.00%$2.05$1.85322,674 shs$58.34 million06/12/2025$1.97$2.00+1.52%$2.00$1.91190,160 shs$59.53 million06/11/2025$2.05$1.97-3.90%$2.10$1.95304,167 shs$58.63 million06/10/2025$1.98$2.05+3.54%$2.09$1.96186,173 shs$61.01 million06/09/2025$2.15$1.98-7.91%$2.49$1.95444,146 shs$58.93 million06/06/2025$2.01$2.15+6.97%$2.15$2.01181,969 shs$63.99 million06/05/2025$2.11$2.01-4.74%$2.18$1.871.56 million shs$59.82 million06/04/2025$2.04$2.11+3.43%$2.17$2.00210,963 shs$62.80 million06/03/2025$2.10$2.04-2.86%$2.15$2.01126,617 shs$60.72 million Related Companies BioAge Labs Stock Price Chart Inhibikase Therapeutics Stock Price Chart Black Diamond Therapeutics Stock Price Chart Neoleukin Therapeutics Stock Price Chart Alector Stock Price Chart Instil Bio Stock Price Chart Galectin Therapeutics Stock Price Chart Lexeo Therapeutics Stock Price Chart Kyverna Therapeutics Stock Price Chart Rapt Therapeutics Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
